I-bark e-Willow ivela emthini wensimbi ( izinhlobo ze- Salix ). Amagxolo aqukethe i-salicin, i-composic chemically efana ne-aspirin. I-salicin isetshenziswe umzimba emzimbeni ku-salicylic acid, okuyisandulela se-aspirin. Ukukhishwa kwemifino kwathandwa njengendlela yokwelapha ubuhlungu, ukuvuvukala, nomkhuhlane. Ngasekupheleni kweminyaka ye-1800, amakhemikhali athola indlela yokwenza inguqulo yokwenza okuthiwa i-acetylsalicylic acid, noma i-aspirin.
Okwenza Abantu basebenzise i-Willow Bark
Kuthiwa amagxolo e-Willow ukusiza ukuphatha ubuhlungu nokuvuvukala kulezi zindaba zezempilo ezilandelayo:
- Ukuhlungu obusemhlane
- Izinwele
- Ubuhlungu bomzimba kanye nezinye izinhlobo zobuhlungu obuhlangene
- I-osteoarthritis
Ngokwezindleko zokulondoloza imali, isifiso sokuhamba konke-imvelo, noma esinye isizathu, i-willow bark ngezinye izikhathi isetshenzisiwe njengenye indlela yezidakamizwa ezingezona ukuvuvukala (non-steroidal anti-inflammatory drugs) (i-NSAID) njenge-aspirin ne-ibuprofen.
I-herb iyatholakala ekwengeziwe, e-tincture, ekhishwe, noma etaweni. Kungatholakala nasemikhiqizo yokunakekela isikhumba, kuhlanganise namafutha nama-salve.
Izinzuzo
Nakhu ukubuka okutholakala eziningana ezivela ocwaningweni olutholakalayo.
1) i-osteoarthritis
Ucwaningo olubili lwe-willow bark olukhishwayo lwe-osteoarthritis lunezinzuzo ezingafani. Esicwaningweni esanyatheliswa ku- Phytotherapy Research ngo-2001, ukuphumelela kwesikhukhula se-willow bark ukunikeza 240 mg salicin nsuku zonke kuqhathaniswa a placebo kubantu 78 abane-osteoarthritis. Ngemuva kwamasonto amabili okwelashwa, izibalo zobuhlungu (ku-WOMAC Osteoarthritis Index) kulabo abathatha amagxolo e-willow bancishiswe ngamaphesenti angu-14 uma kuqhathaniswa nalabo abathatha indawo ye-placebo ababenezinyathelo ezimbili zokunyuka kwezikolo zobuhlungu.
Ucwaningo lwamaviki ayisithupha olwanyatheliswa kuyi- Journal of Rheumatology ngo-2004 luhlolisise ukuphepha nokusebenza kwamagxolo ezimhlophe ezimhlophe abantu abangu-127 abane-hip kanye / noma i-knee osteoarthritis nabantu abangu-26 abane-arthritis ye-rheumatoid. Esivivinyweni se-osteoarthritis, abantu bathola amagxolo e-willow anikeza 240 mg salicin, 100 mg wemithi yediclogenac, noma i-placebo nsuku zonke.
Abantu esilingo sama-arthritis se-rheumatoid bathola i-willow amagxolo noma i-placebo. Imiphumela yathola ukuthi i-diclofenac, kodwa hhayi i-white willow bark, yayiphumelela kakhulu kune-placebo kubantu abane-osteoarthritis. Ezigulini ze-arthritis ze-rheumatoid, i-willow amagxolo ayiphumelelanga kakhulu kune-placebo.
2) Ubuhlungu obubuyela emuva
Ngombiko oshicilelwe ku- Database Cochrane Yokuhlola Okuhlelekile ngo-2016, abacwaningi bahlaziya ukuhlolwa kwemitholampilo eshicilelwe ngaphambilini emithonjeni yemithi yokwelashwa okuphansi emuva. I-willow bark emhlophe (uSalix alba) yabonakala ukunciphisa ubuhlungu ngaphezu kwe-placebo, kodwa izinga lemfundo ebuyekeziwe libhekwa njengokulinganisela okungcono. Azikho izenzakalo ezimbi eziphawulekayo ezaziwa.
Imiphumela Ezingenakwenzeka
I-bark e-Willow iqukethe i-salicylates, ngakho-ke izinyathelo ezifanayo ezifana ne-aspirin kufanele zithathwe kuze kube yilapho ucwaningo luboniswe ngenye indlela. Akufanele kuthathwe isikhathi eside noma ngokulinganiselwa ngokweqile.
Abantwana, abasha, nabancancisayo abesifazane akufanele bathathe amagxolo e-willow. Njenga-aspirin, kukhona ingozi yesimo esingavamile, kodwa esibi futhi ngesinye isikhathi esibulalayo esibizwa ngokuthi i-Reye's syndrome.
Ukuphepha kwamagxolo e-willow ngesikhathi sokukhulelwa akukwaziwa, ngakho kungaba ngcono ukugwema ukuyisebenzisa.
Abantu abane-aspirin noma i-salicylate ukungezwani komzwelo noma ukuzwela akufanele kuthathe i-willow extract.
Olunye ucwaningo lubonisa ukuthi abantu abanesilonda, ukushaya kwenhliziyo, isibindi noma isifo sezinso, i-anemia, i-hemophilia, i-hypoprothrombinemia, i-gout, i-hyperuricemia, noma i-asthma kungadingeka ukuba igweme amagxolo e-willow.
I-bark e-Willow ingathatha isikhathi sokuphuza. Akufanele kuthathwe ngezidakamizwa ze-anticoagulant noma antiplatelet noma izithako ezithengiswayo, njenge-warfarin, izidakamizwa ezingezona isifo sokuvuvukala (NSAIDS), i-ginkgo, i-vitamin E, noma i-garlic, noma abantu abanenkinga yokuphapha. Akufanele kuthathwe ngaphambi kokuhlinzwa. Amagxolo omile angase axhumane neminye imithi .
Imiphumela emibi efanayo njengoba i-aspirin ingase ibe khona ngokweqile. Ngenkathi imiphumela emibi ivame ukuba mnene, isisu esidabukisayo, izilonda, isicanucanu, ukukhala ezindlebeni, ukuphuma kwegazi esiswini / emathunjini kanye nezilonda, isicanucanu, ubuthi obushukela, ukuqhuma, isisu, nokulimala kwezinso kuye kwabikwa.
Kubalulekile ukwazi ukuthi ungasebenzisa kanjani izithako ngokuphepha .
Ukusebenzisa i-White Willow Bark
Uma ufuna indlela yemvelo yokuphumula ubuhlungu futhi ucabangela ukusebenzisa i-willow amagxolo, khuluma nomhlinzeki wakho oyinhloko wokunakekelwa kuqala ukuxoxa uma kukufanelekile.
Imithombo:
> Biegert C, Wagner I, uLudtke R, et al. Ukusebenza nokuphepha kwe-willow bark ekhishwe ekwelapheni i-osteoarthritis ne-rheumatoid arthritis: imiphumela yezivivinyo ezimbili ezilawulwa kabili ezingahleliwe. J Rheumatol. 2004 Nov; 31 (11): 2121-30.
> Gagnier JJ, Oltean H, van Tulder MW, Berman BM, Bombardier C, Robbins CB. Imithi Yamagciwane Embuzweni Ophansi Emuva: Ukubuyekezwa Kwe-Cochrane. Isiphambano (Phila Pa 1976). 2016 Jan; 41 (2): 116-33.
> Schmid B, uLüdtke R, uSelbmann HK, et al. Ukusebenza nokubekezelelana kwesikhwama se-willow bark esilinganiselwe ezigulini ezine-osteoarthritis: ukulawulwa kwe-placebo okungahleliwe, ukuhlolwa kwe-clinical blind blind. I-Phytother Res. 2001 Jun; 15 (4): 344-50.
Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela olayisensi. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.